• Hillrom
  • Hillrom 900 Accella
  • Mortara
  • Bariatric Care
  • Hillrom To Host Fiscal Fourth Quarter 2019 Earnings Conference Call And Webcast

    CHICAGO, Sept. 19, 2019 - Hillrom (NYSE: HRC), will host its fiscal fourth quarter 2019 earnings conference call and webcast on Friday, November 1, 2019, beginning at 7:00 a.m. (CT) / 8:00 a.m. (ET).

    Hillrom Announces Launch of $425 Million Private Placement

    CHICAGO, Sept. 5, 2019 - Hill-Rom Holdings, Inc. ("Hillrom" or the "Company") (NYSE: HRC) today announced the planned private offering, subject to market and other conditions, of $425 million in aggregate principal amount of senior unsecured notes (the "Notes"). The Notes will be guaranteed on a senior unsecured basis by certain of Hillrom's existing and future wholly owned domestic restricted subsidiaries.

    Hillrom Reports Fiscal Third Quarter Financial Results

    CHICAGO, Aug. 2, 2019 - Hillrom (NYSE: HRC) today announced financial results for the fiscal third quarter ended June 30, 2019, and provided its fiscal fourth quarter and updated full-year 2019 financial outlook.

    Hillrom Announces Acquisition Of Breathe Technologies

    CHICAGO, August 2, 2019 - Hillrom (NYSE: HRC) announced today that it has entered into a definitive agreement to acquire Breathe Technologies, Inc., developer and manufacturer of a patented wearable, non-invasive ventilation technology that supports improved patient mobility, for a cash consideration of $130 million.

    Hillrom Introduces Next-Generation Breakthrough Technology In Fight Against Diabetic Retinopathy

    CHICAGOJuly 29, 2019 - Hillrom announced today its latest innovation in vision screening and diagnostics with the introduction of the Welch Allyn® RetinaVue® 700 Imager handheld retinal camera, part of the RetinaVue® Care Delivery Model that enables remote ophthalmologists to diagnose diabetic retinopathy in patients with diabetes during routine primary care office visits. Diabetic retinopathy is the leading cause of blindness in working-age adults1.